These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12534776)

  • 1. Overview: past and future of immunologic intervention in the pathogenesis, prophylaxis and therapeusis of hepatitis B.
    Hilleman MR
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S449-51. PubMed ID: 12534776
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B vaccination among the Nicobarese tribe: Need to document the impact.
    Murhekar M
    Indian J Med Res; 2015 May; 141(5):662. PubMed ID: 26139786
    [No Abstract]   [Full Text] [Related]  

  • 3. Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications.
    Hilleman MR
    Vaccine; 2001 Feb; 19(15-16):1837-48. PubMed ID: 11228353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we need better hepatitis B vaccines?
    Gerlich WH
    Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
    [No Abstract]   [Full Text] [Related]  

  • 5. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
    Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K
    Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963
    [No Abstract]   [Full Text] [Related]  

  • 7. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis B vaccine].
    Kurokohchi K; Kuriyama S
    Nihon Rinsho; 2005 May; 63 Suppl 5():638-42. PubMed ID: 15954422
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial overview: Antiviral strategies: Virological and immunological basis for HBV cure.
    Urban S; Bertoletti A
    Curr Opin Virol; 2018 Jun; 30():iv-vi. PubMed ID: 29866361
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B vaccines: WHO position paper – July 2017.
    Wkly Epidemiol Rec; 2017 Jul; 92(27):369-92. PubMed ID: 28685564
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).
    Page M; Jones CD; Bailey C
    Intervirology; 2001; 44(2-3):88-97. PubMed ID: 11509870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.
    Cooper B
    Compr Ther; 1989 Jul; 15(7):9-15. PubMed ID: 2527714
    [No Abstract]   [Full Text] [Related]  

  • 13. Current practice in testing for hepatitis B virus carriage in non-seroconverters.
    Griffiths I; Dornan J; Aston I
    Occup Med (Lond); 2001 Dec; 51(8):517-8. PubMed ID: 11741087
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B Virus Immunization Before and After Pediatric Liver Transplantation: Check, Catch-Up, and Check Again!
    L'Huillier AG; McLin VA; Posfay-Barbe KM
    Am J Transplant; 2015 Aug; 15(8):2275-6. PubMed ID: 26014457
    [No Abstract]   [Full Text] [Related]  

  • 15. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies.
    Akcay IM; Katrinli S; Ozdil K; Doganay GD; Doganay L
    World J Gastroenterol; 2018 Aug; 24(30):3347-3360. PubMed ID: 30122875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first identified hepatitis B virus vaccine escape mutation in Turkey.
    Kutlu T; Soycan LY; Karatayli E; Türkyilmaz AR; Yurdaydin C; Bozdayi AM
    J Clin Virol; 2006 Feb; 35(2):201-2. PubMed ID: 16230046
    [No Abstract]   [Full Text] [Related]  

  • 17. [The assessment of efficacy of hepatitis B prophylaxis in children with acute lymphoblastic leukemia].
    Moryl-Bujakowska A; Czogała M; Czogała W; Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():85-8. PubMed ID: 15686054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B vaccine in patients with human immunodeficiency virus infection].
    Ramírez O CA; Fernández A DG; Valderrama B SL; Gómez Q CH; Támara R JR; Alvarez M CA
    Rev Chilena Infectol; 2009 Feb; 26(1):26-33. PubMed ID: 19350156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to L'Huillier et al.
    Leung DH; Ton-That M; Economides JM; Healy CM
    Am J Transplant; 2015 Aug; 15(8):2277. PubMed ID: 26014288
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.
    Michel ML; Loirat D
    Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.